J.P. Morgan European Healthcare Symposium

Harness Therapeutics will be attending the J.P. Morgan European Healthcare Symposium in London on 10 June.

Bringing together emerging healthcare companies, investors and industry leaders from across Europe, the symposium provides an opportunity to discuss the investment landscape, healthcare innovation and trends shaping the future of healthcare.

We're looking forward to joining the conversation and connecting with others working to advance the next generation of therapies.

If you're attending and would like to meet with Jan Thirkettle, he'd be very pleased to connect!

#HealthcareInnovation #Biotech #LifeSciences #DrugDevelopment #HealthcareInvestment #Biotechnology #Networking

Our programmes

Huntington's Disease

Discover more

ALS and Alzheimer's

Discover more

Parkinson’s Disease

Discover more

Our news

June 2026

Harness Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance Parkinson's Disease Programme

February 2026

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington’s Disease and Establishes Clinical Advisory Board

October 2025

Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture Investment

June 2025

Harness Therapeutics Publishes HTT CAG Repeat Sizing Methodology Code on GitHub

View all